As a result, most patients and even many doctors have no idea that a better cholesterol ... But he says that another number on the standard lipid panel effectively conveys the same information: ...
Pfizer has announced results from a Phase 2b study of bococizumab, its candidate for patients with hard-to-treat raised cholesterol. Bococizumab (RN316) is one of a new class of drugs which ...
In clinical practice, a combination of drugs is often used to treat patients with dyslipidemia who are not achieving their treatment goals. Ezetimibe reduces LDL cholesterol levels, and niacin ...
We realised that a tool that would produce information on the cellular functions of individual persons would benefit patients, healthcare providers and pharmaceutical companies. It is precisely these ...